Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies (original) (raw)

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses

Enzo Ierardi

Alimentary Pharmacology and Therapeutics, 2005

View PDFchevron_right

Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies

JD J D de Korwin

Alimentary Pharmacology and Therapeutics, 2003

View PDFchevron_right

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy

Virginia Festa

Alimentary Pharmacology and Therapeutics, 2001

View PDFchevron_right

Comparison of efficacies of dual therapy and triple therapy using rabeprazole in second-line eradication of Helicobacter pylori in Japan

Emiko Rimbara

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

To compare efficacy of 10-day sequential triple therapy versus 14-days sequential therapy for the eradication of H. pylori

Dr. Ns Neki

International Journal of Current Research in Medical Sciences, 2017

View PDFchevron_right

A comparison of 5 or 7 days of rabeprazole triple therapy for eradication of Helicobacter pylori

Murdani Abdullah

Medical Journal of Indonesia, 2010

View PDFchevron_right

Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer

Filiz Akyüz

Southern Medical Journal, 2011

View PDFchevron_right

A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study

Brendan Crotty

Gastroenterology, 2002

View PDFchevron_right

Maedica-a Journal of Clinical Medicine A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori Infection A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF TWO ERADICATION REGIMENS FOR HELICOBACTER PYLORI INFECTION

Carmen Preda

2017

View PDFchevron_right

Rabeprazole-based therapies in Helicobacter pylori eradication

Xavier Calvet

Alimentary Pharmacology and Therapeutics, 2003

View PDFchevron_right

A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates

Martin Houben

Aliment Pharmacol Therapeut, 1999

View PDFchevron_right

Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication: A Multicentre, Double-Blind, Randomised Clinical Trial

Arturo Fueyo

Clinical Drug Investigation, 2001

View PDFchevron_right

Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study

R. Igetei, Stella Smith

World Journal of Gastroenterology, 2014

View PDFchevron_right

A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori Infection

Carmen Preda

Maedica, 2017

View PDFchevron_right

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens

Smilja Kalenic

Helicobacter, 2009

View PDFchevron_right

The <i>Helicobacter pylori</i> Eradication Rate in a High Prevalence Area (West Africa): Three Triple Therapy Comparative Study

Alassan Mahassadi

Open Journal of Gastroenterology, 2015

View PDFchevron_right

Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line

Lucia Fini

World Journal of Gastroenterology, 2012

View PDFchevron_right

Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy

Virginia Festa

Alimentary Pharmacology and Therapeutics, 2003

View PDFchevron_right

A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori

Niraj Shah

The American Journal of Gastroenterology, 2011

View PDFchevron_right

Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure

Pasquale Berloco

Alimentary Pharmacology and Therapeutics, 2004

View PDFchevron_right

Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial

Jawtown Lin

Journal of Antimicrobial Chemotherapy, 2011

View PDFchevron_right

A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates

Mohammed Fazel

Journal of Gastroenterology and Hepatology, 2001

View PDFchevron_right

The &lt;i&gt;Helicobacter pylori&lt;/i&gt; Eradication Rate in a High Prevalence Area (West Africa): Three Triple Therapy Comparative Study

Aboubacar Demba Bangoura

Open Journal of Gastroenterology, 2015

View PDFchevron_right

A Randomized Clinical Trial to Determine the Efficacy of Regimens Containing Clarithromycin, Metronidazole, and Amoxicillin Among Histologic Subgroups for Helicobacter pylori Eradication in a Developing Country

Juan Jimenez Bravo

Helicobacter, 2009

View PDFchevron_right

Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori: A Multicenter Multinational Randomized Controlled Trial

Eman abdelsameea

Middle East Journal of Digestive Diseases, 2023

View PDFchevron_right

First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy

Cesare Efrati, Lorenzo Ridola, Domenico Alvaro

Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2014

View PDFchevron_right

Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial

Rejane Mattar, Ana Cristina S Teixeira

Gastroenterology Research and Practice, 2015

View PDFchevron_right